EZViable? Calcein AM Cell Viability Assay Kit (Fluorometric)

K305-1000
EUR 359

Carbonic Anhydrase (CA) Activity Assay Kit (Colorimetric)

K472-100
EUR 550

AM-679

B2521-1
EUR 153

AM-679

B2521-5
EUR 430

AM 281

B6603-10 10 mg
EUR 195
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain.

AM 281

B6603-5 5 mg
EUR 125
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain.

AM 281

B6603-50 50 mg
EUR 635
Description: AM 281 is a potent and selective antagonist/inverse agonist of CB1 cannabinoid receptor with Ki values of 12 and 4200 nM for CB1 and CB2 receptors, respectively [1].CB1 cannabinoid receptor is a G protein-coupled receptor and is mainly expressed in the brain.

AM 404

B6604-100 100 mg
EUR 419
Description: AM 404 is a selective inhibitor of anandamide transport [1]. Also, it is an agonist of CB1 cannabinoid receptor and potential vanilloid type 1 (TRPV1).

AM 404

B6604-50 50 mg
EUR 261
Description: AM 404 is a selective inhibitor of anandamide transport [1]. Also, it is an agonist of CB1 cannabinoid receptor and potential vanilloid type 1 (TRPV1).

BAPTA-AM

B4758-10 10 mg
EUR 128
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4].

BAPTA-AM

B4758-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4].

BAPTA-AM

B4758-50 50 mg
EUR 325
Description: BAPTA-AM is a selective calcium chelator [1]. Ca2+ is one of the most ubiquitous and versatile intracellular signaling molecules that control numerous cellular processes such as neurotransmitter release, contraction of all muscle cell types and fertilization [4].

BCECF-AM

B5370-1 1 mg
EUR 160

BCECF-AM

B5370-25 25 mg
EUR 2111

BCECF-AM

B5370-5 5 mg
EUR 545

AM 1172

B7392-10 10 mg
EUR 235
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides.

AM 1172

B7392-100 100 mg
EUR 1414
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides.

AM 1172

B7392-5 5 mg
EUR 147
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides.

AM 1172

B7392-50 50 mg
EUR 830
Description: AM 1172 is a potent and selective inhibitor of stable anandamide uptake with IC50 of 2.43102.5 ?M and fatty acid amide hydrolase (FAAH) with Ki of 3.18 ?M. FAAH, is an integral membrane hydrolase that hydrolyzes bioactive amides.

AM-2394

HY-100221 10mM/1mL
EUR 216

BAPTA-AM

HY-100545 50mg
EUR 436

AM-2099

HY-100727 10mM/1mL
EUR 361

BCECF-AM

HY-101883 1mg
EUR 316

AM-0902

HY-108329 100mg
EUR 1153

RT-AM

HY-108715A 1mg
EUR 452

Calcein-AM

HY-D0041 100ug
EUR 147

EGTA-AM

HY-D0973 5mg
EUR 587

AM-4668

HY-12585 5mg
EUR 371

AM-1638

HY-13467 5mg
EUR 452

AM 103

HY-14163 1mg
EUR 2254

Calcein-AM

GT0291-1MG 1 mg
EUR 341

SBFI-AM

GK8201-1MG 1 mg
EUR 628

AM resin

20-abx095149
  • EUR 314.00
  • EUR 592.00
  • EUR 885.00
  • 100 g
  • 250 g
  • 500 g
  • Shipped within 5-10 working days.

AM-095

9581-25
EUR 588

AM-095

9581-5
EUR 185

AM 114

A8163-10 10 mg
EUR 119
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M

AM 114

A8163-25 25 mg
EUR 189
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M

AM 114

A8163-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M

AM 114

A8163-50 50 mg
EUR 282
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M

AM 114

A8163-S Evaluation Sample
EUR 81
Description: AM 114, a derivative of boronic chalcone, is a potent small-molecule inhibitor of the proteasome that inhibits the chymotrypsin-like activity of the 20S proteasome, with a value of 50% inhibition concentration IC50 of approximately 1 ?M

Calcein AM

1755-1000
EUR 370

Calcein AM

1755-250
EUR 327

Calcein AM

1755-50
EUR 131

NAADP-AM

21000 1 mg
EUR 876
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

BCECF, AM

21202 1 mg
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

BAPTA AM

2242-25
EUR 262

BAPTA AM

2242-5
EUR 109

cAMP AM

20300 1 mg
EUR 50
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

NAADP-AM

20997 2X50 ug
EUR 306
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

NAADP-AM

20998 250 ug
EUR 393
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

AM-251

B2718-25 25 mg
EUR 510

AM-251

B2718-5 5 mg
EUR 166

AM-92016 Hydrochloride

B2569-25
EUR 631

AM-92016 Hydrochloride

B2569-5
EUR 196

AM 92016 hydrochloride

B6482-10 10 mg
EUR 318
Description: AM 92016 hydrochloride is a specific inhibitor of delayed rectifier potassium current [1]. Potassium channel is an ion channel and acts to reset the resting potential and shapes the action potential.

AM-095 Sodium

B1225-25
EUR 631

AM-92016 (hydrochloride)

HY-101253 10mM/1mL
EUR 176

Fluo-4 AM

HY-101896 100ug
EUR 546

Fura-2 AM

HY-101897 1mg
EUR 408

Indo-1 AM

HY-101898 1mg
EUR 366

Rhod-2 AM

HY-D0989 1mg
EUR 436

Fura 2-AM

GK3824-1MG 1 mg
EUR 269

FURA-4F/AM

9550-50
EUR 131

FURA-4F/AM

9550-set
EUR 349

FURA-5F/AM

9551-50
EUR 137

FURA-5F/AM

9551-set
EUR 398

Calcein AM, (20x50ug)

80011-3 20ST
EUR 242
Description: Minimum order quantity: 1 unit of 20ST

BAPTA, AM ester

50000 25MG
EUR 205
Description: Minimum order quantity: 1 unit of 25MG

BAPTA, AM ester

50000-1 20MG
EUR 243
Description: Minimum order quantity: 1 unit of 20MG

BCECF, AM ester

51012 1MG
EUR 137
Description: Minimum order quantity: 1 unit of 1MG

Rhod-FF, AM

21077 1 mg
EUR 306
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Rhod-FF, AM

21078 10x50 ug
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

FURA-2 Am

2243-1
EUR 262

FURA-2 Am

2243-set
EUR 153

Fluo-2, AM

20494 10x50 ug
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Fluo-2, AM

20495 1 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Poricoic acid AM

TBW00284 10mg
EUR 1295

CA/ Rat CA ELISA Kit

ELA-E0875r 96 Tests
EUR 886

AN3 CA

C0026002 One Frozen vial
EUR 543

CA-074

HY-103350 10mg
EUR 587

CA-5f

HY-112698 5mg
EUR 176

CA 074

A1926-1 1 mg
EUR 148
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-10 10 mg
EUR 485
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-25 25 mg
EUR 746
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5 5 mg
EUR 311
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-5.1 10 mM (in 1mL DMSO)
EUR 432
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA 074

A1926-S Evaluation Sample
EUR 81
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2].

CA-1001

B2669-25 25mg
EUR 591

CA-1001

B2669-5 5mg
EUR 186

CA-074

B2971-1 1 mg
EUR 196